{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:51:12Z","timestamp":1794718272637,"version":"4.9.1"},"reference-count":183,"publisher":"Informa UK Limited","issue":"2","funder":[{"name":"not funded"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2022,1,22]]},"DOI":"10.1080\/14656566.2021.1996562","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T06:47:57Z","timestamp":1636613277000},"page":"175-199","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":19,"title":["Evaluating posaconazole, its pharmacology, efficacy and safety for the prophylaxis and treatment of fungal infections"],"prefix":"10.1080","volume":"23","author":[{"given":"Paraskevi","family":"Panagopoulou","sequence":"first","affiliation":[{"name":"4th Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, and Papageorgiou General Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Roilides","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, 3rd Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, and Hippokration General Hospital, Thessaloniki, Greece"},{"name":"Basic and Translational Research Unit, Special Unit for Biomedical Research and Education, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,11,10]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.3390\/jof3040057"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2016.1257457"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.09.015"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9080445"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-842X(03)00117-3"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2013.04.001"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14472-8"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ933"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1086\/525258"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00163-06"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1586\/17512433.2015.1034689"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.2165\/11319340-000000000-00000"},{"key":"cit0013","unstructured":"Noxafil. EPAR-scientific discussion. [Internet]. London (UK): European Medicines Agency 2005. 1\u201337. [cited 2021 Feb 20]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-discussion\/noxafil-epar-scientific-discussion_en.pdf"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.2.568-574.2004"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.4.501"},{"key":"cit0016","first-page":"2173","volume":"7","author":"Whaley SG","year":"2016","journal-title":"Front Microbiol"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70297-8"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2018.09.010"},{"key":"cit0019","unstructured":"European Medicines Agency. ANNEX I. Summary of product characteristics [Internet]. EMA; 2020. [cited 2021 Feb 02]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/noxafil-epar-product-information_en.pdf."},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.5.1581-1582.2002"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2020.e01007"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.5.2163-2167.2005"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.8.3623-3626.2003"},{"key":"cit0024","unstructured":"Rationale document for EUCAST clinical breakpoints agent posaconazole citation of EUCAST documents [Internet]. 2020. [cited 2021 Feb 17]. Available from: http:\/\/www.EUCAST.org.http:\/\/www.eucast.org."},{"key":"cit0025","unstructured":"Schering-Plough news release. Schering-Schering Plough announces FDA approval of NOXAFIL \u00ae (posaconazole) for prevention of invasive fungal infections. Kenilworth (NJ): Schering-Plough; [Internet]. 2006 [cited 2006 Jan 10]. Available from: http:\/\/www.scheringplough.com\/schering_plough\/news\/release.jsp?releaselD=906202."},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1533"},{"key":"cit0027","author":"Merck &amp; Co.","year":"2020","journal-title":"Noxafil (Posaconazole). Product monograph."},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0348-3"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz360.1422"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106084"},{"key":"cit0031","unstructured":"A phase 2, open-label, non-comparative clinical trial to study the safety and efficacy of posaconazole (POS, MK-5592) in pediatric participants aged 2 to less than 18 years with invasive aspergillosis. EudraCT 2019-002267-10, [Internet]. [cited 2021 Feb 14]. EudraCT 2019-002267-10, [Internet]: www.clinicaltrials.gov."},{"key":"cit0032","unstructured":"A phase 2, open-label, single-arm, sequential-panel study to evaluate the pharmacokinet-ics, safety, and tolerability of posaconazole (POS, MK-5592) intravenous and powder for oral suspension formulations in pediatric participants from birth to <2 years of age with possible, probable, or proven invasive fungal infection. EudraCT 2019-003842-34. [Internet]. [cited 2021 Feb 13]. EudraCT 2019-003842-34. [Internet]: www.clinicaltrials.gov."},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544020-00006"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks268"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.2.658-666.2006"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01306-y"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31824d135c"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.9.2788-2795.2003"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00222-12"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00889-09"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01034-08"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01977.x"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.2165\/11592630-000000000-00000"},{"key":"cit0044","unstructured":"Committee for Medicinal Products for Human Use (CHMP). Posaconazole tablet assessment report. [Internet]. European Medicines Agency; 2014. [cited 2021 Sep 02]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/variation-report\/noxafil-h-c-610-x-0028-epar-scientific-discussion-extension_en.pdf"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00802-12"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02448-13"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03050-14"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv380"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20136-3"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13031"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04035-14"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02686-13"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-019-00833-1"},{"key":"cit0054","unstructured":"Posaconazole Injection, Noxafil. [Internet]. FDA\/Center for drug evaluation and research. 2014 Accessed: 02\/ 03\/ 2021. [Internet]. [Internet]: www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2014\/205596Orig1s000MedR.pdf."},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04223-14"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx263"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.9.3543-3551.2004"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(02)01599-6"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.32.2.267"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02230-17"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1086\/523576"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01341-x"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71571-0"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061094"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061098"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1086\/587177"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.5414\/CP201880"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026772"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw444"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.01.002"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.05.019"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12724"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13675"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.17652"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00581-15"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13020"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30312-3"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1086\/500212"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181837585"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1086\/508774"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2019.04.006"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000235"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.03.015"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00893-18"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.3390\/jof6040281"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1313122"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12529"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2017-0131"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1016\/j.riam.2018.07.008"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2018-0344"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00219-1"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1086\/501457"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1086\/511039"},{"key":"cit0094","unstructured":"European Medicines Agency. Noxafil. EPAR. Product information. ANNEX I summary of product characteristics [Internet]. 2020. [cited 2021 Feb 02]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/noxafil-epar-product-information_en.pdf"},{"issue":"4","key":"cit0095","first-page":"e01292","volume":"65","author":"Beredaki M-I","year":"2021","journal-title":"Antimicrob Agent Chemother"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.3109\/1040841X.2012.711741"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.1007\/s12281-010-0042-6"},{"key":"cit0098","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13028"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2015.10.012"},{"key":"cit0100","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.17"},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.3390\/jof5040097"},{"key":"cit0102","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki288"},{"key":"cit0103","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1562902"},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.1086\/503425"},{"key":"cit0105","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2003.09.033"},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.1016\/j.mmcr.2019.01.002"},{"issue":"3","key":"cit0107","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jac\/dkaa481","volume":"76","author":"Sprute R","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01498-10"},{"key":"cit0109","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt508"},{"key":"cit0110","first-page":"3221","volume":"73","author":"Maertens JA","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"cit0111","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05900-11"},{"key":"cit0112","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.64"},{"key":"cit0113","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3055-3"},{"key":"cit0114","unstructured":"European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP). Posaconazole injection assessment report: EPAR-assessment report-Variation. [Internet]. 2014 [cited 2021 Jan 15]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/variation-report\/noxafil-h-c-610-x-0033-epar-assessment-report-variation_en.pdf."},{"key":"cit0115","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2014.06.001"},{"key":"cit0116","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00484-19"},{"key":"cit0117","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myaa106"},{"key":"cit0118","doi-asserted-by":"publisher","DOI":"10.1007\/s12281-016-0255-4"},{"key":"cit0119","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000877"},{"key":"cit0120","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8878158"},{"key":"cit0121","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009360982"},{"key":"cit0122","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2010.01985.x"},{"key":"cit0123","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa646"},{"key":"cit0124","doi-asserted-by":"crossref","unstructured":"Riat A, Plojoux J, Gindro K, et al. Azole resistance of environmental and clinical aspergillus fumigatus isolates from Switzerland. Antimicrob Agents Chemother [Internet]. 2018 [cited 2021 Aug 22];62. Available from: https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02088-17.","DOI":"10.1128\/AAC.02088-17"},{"key":"cit0125","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30316-X"},{"key":"cit0126","first-page":"1","volume":"3","author":"Sanglard D","year":"2016","journal-title":"Front Med Lausanne"},{"key":"cit0127","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh027"},{"key":"cit0128","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.10.3690-3696.2004"},{"key":"cit0129","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.3.4.467"},{"key":"cit0130","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-010-0957-4"},{"key":"cit0131","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2018.1490177"},{"key":"cit0132","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz359"},{"key":"cit0133","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182195808"},{"key":"cit0134","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13777"},{"key":"cit0135","first-page":"410","volume":"32","author":"Ramos JT","year":"2019","journal-title":"Rev Esp Quimioter"},{"key":"cit0136","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-013-1998-2"},{"key":"cit0137","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-017-2369-7"},{"key":"cit0138","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myv087"},{"key":"cit0139","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-0658-1"},{"key":"cit0140","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-263"},{"key":"cit0141","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212837"},{"key":"cit0142","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000963"},{"key":"cit0143","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1R775"},{"key":"cit0144","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/pix058"},{"key":"cit0145","first-page":"47","volume":"25","author":"Wass EN","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"key":"cit0146","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa377"},{"key":"cit0147","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piy094"},{"key":"cit0148","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001071"},{"key":"cit0149","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12483"},{"key":"cit0150","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-010-1123-8"},{"key":"cit0151","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13017"},{"key":"cit0152","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myz015"},{"key":"cit0153","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000002080"},{"key":"cit0154","unstructured":"European Medicines Agency. Opinion of the paediatric committee on the acceptance of a modification of an agreed paediatric investigation plan (EMEA-000468-PIP02-12-M06). [Internet]. 2020. [cited 2021 Feb 20]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/pip-decision\/p\/0101\/2020-ema-decision-18-march-2020-acceptance-modification-agreed-paediatric-investigation-plan_en.pdf."},{"key":"cit0155","doi-asserted-by":"publisher","DOI":"10.1177\/0091270004271402"},{"key":"cit0156","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn401"},{"key":"cit0157","doi-asserted-by":"publisher","DOI":"10.1517\/13543780903176407"},{"key":"cit0158","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12517"},{"key":"cit0159","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903364657"},{"key":"cit0160","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2483-9"},{"key":"cit0161","doi-asserted-by":"publisher","DOI":"10.21037\/jeccm.2019.08.01"},{"key":"cit0162","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2013.765857"},{"key":"cit0163","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2009.01055.x"},{"key":"cit0164","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182577485"},{"key":"cit0165","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12600"},{"key":"cit0166","doi-asserted-by":"publisher","DOI":"10.1080\/13693780802239105"},{"key":"cit0167","doi-asserted-by":"publisher","DOI":"10.1086\/657306"},{"key":"cit0168","doi-asserted-by":"publisher","DOI":"10.1086\/504328"},{"key":"cit0169","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12871"},{"key":"cit0170","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx122"},{"key":"cit0171","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12851"},{"key":"cit0172","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00188-17"},{"key":"cit0173","volume-title":"54th Interscience Conference on Antimicrobrial Agents and Chemotherapy","author":"Pettit N","year":"2014"},{"key":"cit0174","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.1.40"},{"key":"cit0175","doi-asserted-by":"publisher","DOI":"10.2165\/0003088-200847120-00003"},{"key":"cit0176","doi-asserted-by":"publisher","DOI":"10.1592\/phco.27.6.825"},{"key":"cit0177","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.02.022"},{"key":"cit0178","doi-asserted-by":"publisher","DOI":"10.2147\/DHPS.S6321"},{"key":"cit0179","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X187937"},{"key":"cit0180","volume-title":"42nd Interscience Conference on Antimicrobial Agents and Chemotherapy","author":"Courtney R"},{"key":"cit0181","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01586-13"},{"key":"cit0182","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X167507"},{"key":"cit0183","doi-asserted-by":"publisher","DOI":"10.1080\/088800101753328529"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2021.1996562","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T04:32:41Z","timestamp":1642739561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2021.1996562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,10]]},"references-count":183,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,1,22]]}},"alternative-id":["10.1080\/14656566.2021.1996562"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2021.1996562","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-04-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}